Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01960764

Examination of Whether Host Preconditioning Modifies Short-term Transplant Survival

Phase 1 Study of Whether Host Preconditioning Modifies Short-term Transplant Survival

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of California, San Diego · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Unlike healthy control skin, the skin of patients with atopic dermatitis (AD) is frequently colonized by Staphylococcus aureus (S. aureus), putting these patients at increased risk of S. aureus skin infections. In addition, research in the investigator's lab has shown that these patients have fewer protective antimicrobial Staphylococcal species such as Staphylococcal epidermidis (S. epidermidis) known to produce antimicrobial peptides that play a role in protecting the skin from invading pathogens. In this study, the investigator will attempt to decrease S. aureus colonization and increase colonization by protective Staph species. First the investigator will culture the bacteria on subjects' lesional AD skin. The investigator will selectively grow the subject's antimicrobial Staph colonies and place them into a base moisturizer. The moisturizer plus bacteria will be applied to both of the subject's arms. Prior to applying this, though, one arm will first be pre-treated with an antimicrobial regiment of Dial liquid antibacterial soap and alcohol. We will then compare the abundance of antimicrobial Staph species on each subject's arms 24 hours later to determine whether the pre-treatment regimen increased survival of the transplanted antimicrobial Staph species. The investigator expects that the arm pre-treated with the antimicrobial regimen will have more antimicrobial Staph species at this time point.

Conditions

Interventions

TypeNameDescription
DRUGPre-Treatment with Dial liquid antibacterial soapThis arm will be pre-treated with Dial liquid antibacterial soap and alcohol prior to the autologous microbiome transplant.
OTHERControl

Timeline

Start date
2016-06-01
Primary completion
2022-06-01
Completion
2022-12-01
First posted
2013-10-11
Last updated
2020-11-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01960764. Inclusion in this directory is not an endorsement.